These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 2419362)

  • 1. Nature of the glomerular capillary injury in human membranous glomerulopathy.
    Shemesh O; Ross JC; Deen WM; Grant GW; Myers BD
    J Clin Invest; 1986 Mar; 77(3):868-77. PubMed ID: 2419362
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional nature of glomerular injury in progressive diabetic glomerulopathy.
    Tomlanovich S; Deen WM; Jones HW; Schwartz HC; Myers BD
    Diabetes; 1987 May; 36(5):556-65. PubMed ID: 2436961
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanism of the antiproteinuric effect of indomethacin in nephrotic humans.
    Golbetz H; Black V; Shemesh O; Myers BD
    Am J Physiol; 1989 Jan; 256(1 Pt 2):F44-51. PubMed ID: 2463770
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of cyclosporin A on glomerular barrier function in the nephrotic syndrome.
    Zietse R; Wenting GJ; Kramer P; Schalekamp MA; Weimar W
    Clin Sci (Lond); 1992 Jun; 82(6):641-50. PubMed ID: 1320544
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glomerular capillary wall function in human lupus nephritis.
    Friedman S; Strober S; Field EH; Silverman E; Myers BD
    Am J Physiol; 1984 May; 246(5 Pt 2):F580-91. PubMed ID: 6720964
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of colloid volume expansion on glomerular barrier size-selectivity in humans.
    Shemesh O; Deen WM; Brenner BM; McNeely E; Myers BD
    Kidney Int; 1986 Apr; 29(4):916-23. PubMed ID: 3712975
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional response of healthy and diseased glomeruli to a large, protein-rich meal.
    Chan AY; Cheng ML; Keil LC; Myers BD
    J Clin Invest; 1988 Jan; 81(1):245-54. PubMed ID: 3275694
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Angiotensin-converting enzyme inhibition prevents loss of glomerular hydraulic permeability in passive heymann nephritis.
    Remuzzi A; Monaci N; Bonassi ME; Corna D; Zoja C; Mohammed EI; Remuzzi G
    Lab Invest; 1999 Dec; 79(12):1501-10. PubMed ID: 10616201
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanisms of proteinuria in human glomerulonephritis.
    Myers BD; Okarma TB; Friedman S; Bridges C; Ross J; Asseff S; Deen WM
    J Clin Invest; 1982 Oct; 70(4):732-46. PubMed ID: 6181095
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Permselectivity of of the glomerular capillary wall. Studies of experimental glomerulonephritis in the rat using neutral dextran.
    Chang RL; Deen WM; Robertson CR; Bennett CM; Glassock RJ; Brenner BM; Troy JL; Ueki IF; Rasmussen B
    J Clin Invest; 1976 May; 57(5):1272-86. PubMed ID: 1262471
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Angiotensin converting enzyme inhibition ameliorates glomerular filtration of macromolecules and water and lessens glomerular injury in the rat.
    Remuzzi A; Puntorieri S; Battaglia C; Bertani T; Remuzzi G
    J Clin Invest; 1990 Feb; 85(2):541-9. PubMed ID: 1688888
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanisms of proteinuria in diabetic nephropathy. II. A study of the size-selective glomerular filtration barrier.
    Friedman S; Jones HW; Golbetz HV; Lee JA; Little HL; Myers BD
    Diabetes; 1983 May; 32 Suppl 2():40-6. PubMed ID: 6086024
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Permselectivity of the glomerular capillary wall. Studies of experimental glomerulonephritis in the rat using dextran sulfate.
    Bennett CM; Glassock RJ; Chang RL; Deen WM; Robertson CR; Brenner BM; Troy JL; ueki IR; Rasmussen B
    J Clin Invest; 1976 May; 57(5):1287-94. PubMed ID: 1262472
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transport of molecules across renal glomerular capillaries.
    Brenner BM; Baylis C; Deen WM
    Physiol Rev; 1976 Jul; 56(3):502-34. PubMed ID: 778868
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Murine lupus nephritis. A structure-function study.
    Kiberd BA
    Lab Invest; 1991 Jul; 65(1):51-60. PubMed ID: 2072665
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Charge selectivity of proteinuria in diabetic glomerulopathy.
    Nakamura Y; Myers BD
    Diabetes; 1988 Sep; 37(9):1202-11. PubMed ID: 3410164
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proteinuria and functional characteristics of the glomerular barrier in diabetic nephropathy.
    Carrie BJ; Myers BD
    Kidney Int; 1980 May; 17(5):669-76. PubMed ID: 6157049
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determinants of glomerular filtration in experimental glomerulonephritis in the rat.
    Maddox DA; Bennett CM; Deen WM; Glassock RJ; Knutson D; Daugharty TM; Brenner BM
    J Clin Invest; 1975 Feb; 55(2):305-18. PubMed ID: 1127101
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extent and course of glomerular injury in human membranous glomerulopathy.
    Guasch A; Sibley RK; Huie P; Myers BD
    Am J Physiol; 1992 Dec; 263(6 Pt 2):F1034-43. PubMed ID: 1282782
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intravenously administered frusemide increases glomerular permeability.
    Ala-Houhala I; Vapaatalo H; Pasternack A
    Clin Sci (Lond); 1987 Oct; 73(4):365-70. PubMed ID: 3665358
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.